This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's Portfolios of the Week

(Updated to add portfolio.)

By Roberto Pedone

Not a Stockpickr member? Join the community today -- for free.

According to Jim Cramer, the the oil futures markets are being manipulated. Cramer strongly believes that the futures market isn't the real deal, because if it were, the price of crude oil would have never reached $140. Cramer thinks any opposition to reforming the futures market should be stopped. He is publically supporting Gary Gensler, the new head of the Commodities Futures Trading Commission.

Despite that support, Cramer feels that the futures traders are far too powerful and connected in Washington to be stopped. He believes that the futures industry will lobby Congress, ask for support from the academic world and manipulate the mainstream media to back its position that the futures markets are too big to be controlled.

Cramer thinks we need a new market leader to complete the trifectra that was oil, tech and banks, now that we might have lost oil due to the manipulators. That new market leader is health care. Cramer is recommending drug stocks such as Gilead (GILD - Get Report) and Abbott Labs (ABT - Get Report), both of which he holds in his charitable trust, Action Alerts PLUS.

Recently, Cramer found opportunity in natural gas stocks, including Chesapeake (CHK - Get Report); stocks that could be the new market leaders, such as Allscripts (MDRX - Get Report); and gold stocks, including Agnico-Eagle (AEM - Get Report). Here are some Cramer highlights from over the past week as aggregated from his "Mad Money" TV show, the "Stop Trading!" segment on CNBC and his RealMoney blog posts. (These blog posts might require a RealMoney subscription.)

To read more, visit Stockpickr.com.

Stockpickr is a wholly owned subsidiary of TheStreet.com.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Submit an article to us!
SYM TRADE IT LAST %CHG
ABT $46.69 0.00%
AEM $31.73 0.00%
CHK $16.54 0.00%
GILD $105.01 0.00%
MDRX $13.30 0.00%

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs